About
Therapeutics
Areas of Focus
Categories
Biologics & BiopharmaceuticalBoston & New England
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
30,024
By Phase
PHASE1: 1PHASE2: 1
By Status
ACTIVE_NOT_RECRUITING: 2RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06797375Lead Sponsor
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of RLYB116 in Healthy Participants
PHASE1Recruiting
16 participants
Started: Apr 14, 2025 · Completed: Jun 30, 2026
NCT06435845Lead Sponsor
Phase 2 Study on the Pharmacokinetics and Safety of RLYB212 in Pregnant Women at Higher Risk for HPA-1a Alloimmunization
PHASE2Active, not recruiting
8 participants
Started: Nov 21, 2024 · Completed: May 31, 2027
NCT05345561Lead Sponsor
Study to Assess the Occurrence of HPA-1a Alloimmunization in Women With Higher Risk for Fetal and Neonatal Alloimmune Thrombocytopenia
N/AActive, not recruiting
30,000 participants
Started: Mar 14, 2022 · Completed: Oct 31, 2025
Locations (1)
Headquarters
New Haven, CT, United States
Map
Loading map...